Buffered penicillin G potassium vials may actually contain cefazolin for injection
Buffered Penicillin G Potassium for Injection is being recalled because some vials of cefazolin for injection were incorrectly labeled as penicillin G potassium 20 million units.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I recall, which the rubric floors at Severe; no injury is reported in the source, so it does not escalate to Critical.
Plain-English summary
Buffered Penicillin G Potassium for Injection, USP, 20,000,000 units, for intravenous use, sterile, prescription only, manufactured in Austria by Sandoz GmbH for Sandoz Inc. of Princeton, New Jersey, NDC 0781-6136-94, is being recalled. The source does not state a quantity.
The stated reason is a label mix-up: some vials of Cefazolin for Injection, USP 1 gram were incorrectly labeled as Penicillin G Potassium for Injection, USP, 20 million Units. The FDA classified the action as Class I, its most serious classification.
Affected lots are PG4360 and PG4362, expiring 11/30/2027. Distribution was nationwide in the USA. The vials are supplied to healthcare facilities rather than sold to consumers.
Facilities should identify affected stock using the NDC and lot numbers above, quarantine it, and follow the instructions issued by Sandoz.
The recalled product
- Product
- PENICILLIN G POTASSIUM (PENICILLIN G POTASSIUM)
- Brand
- PENICILLIN G POTASSIUM
- Manufacturer
- Sandoz Inc
- Category
- Drug — Injectable antibiotic
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot # PG4360
- PG4362
- Exp. 11/30/2027
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Sandoz Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Sandoz Inc
See all →- LowFocalin XR 5mg capsules carry incorrect or missing lot and expiry
FDA (Drugs) · 2026-06-24
- ModerateCyclophosphamide injection vials recalled after a transportation temperature excursion
FDA (Drugs) · 2025-09-24
- ModerateCiprofloxacin and dexamethasone otic suspension recalled following temperature abuse
FDA (Drugs) · 2025-09-17
- SevereSandoz cefazolin cartons contained vials labeled as penicillin G potassium
FDA (Drugs) · 2025-07-09
- HighFDA Recalls Orphenadrine Citrate Tablets Due to Nitrosamine Impurity
FDA (Drugs) · 2022-04-13
Same hazard · label mix up
See all →- HighAmphetamine extended-release capsules contain immediate-release pellets after label mix-up
FDA (Drugs) · 2026-07-08
- ModerateEye drops recalled nationwide due to labeling mix-up
FDA (Drugs) · 2025-01-08
- HighPrescription Drug Sunitinib Malate Subject to Label Mix-Up Recall
FDA (Drugs) · 2024-12-11
- HighSunitinib Malate Capsules Recalled Due to Label Mix-Up
FDA (Drugs) · 2024-12-11
- ModerateWindsor Black Peppercorns Mislabeled; Contains Pink Himalayan Salt Instead
FDA (Food) · 2024-04-24